ABSTRACT
INTRODUCTION
Epstein-Barr virus (EBV), a predominantly B-lymphotropic herpesvirus, is the causative agent of infectious mononucleosis (IM), a self-limiting lymphoproliferative disease seen in some cases of primary infection, and is linked to a range of malignancies that arise as rare accidents of long-term virus carriage 1 . Despite its pathogenic potential, EBV is widespread in human populations, is usually acquired sub-clinically and is carried by the vast majority of individuals as a latent, asymptomatic infection of the re-circulating B cell pool. Fractionation of B cell subsets in the blood of such carriers has shown that the virus is harboured selectively within IgD -CD27 + cells, i.e within the classical isotype-switched memory B cell population 2, 3 . Physiologically, this population thereafter the physiologic processes of GC transit come into play and deliver latently-infected GC progeny cells into the long-lived memory compartment 3, [7] [8] [9] [10] . Another hypothesis, based largely on the study of individual infected cells in IM lymphoid tissues, questions the involvement of the GC reaction in this context and envisages either the preferential infection of memory cells or the preferential expansion/survival of memory cells post-infection, compared to their naïve counterparts [11] [12] [13] .
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To inform this debate, one approach is to examine EBV infection in patients with immune deficiencies characterised by an inability to generate class-switched memory B cell responses.
Typically, the circulating B cell pool of such patients is dominated by IgD + CD27 -naïve B cells.
The remaining cells are immature bone marrow-derived transitional B cells (distinguished by CD10 expression and normally present in very low numbers in healthy donor blood) and a small population of IgM + IgD + CD27 + cells that express mutated IgV sequences [14] [15] [16] ; these latter cells have been referred to as IgM-memory or non-switched memory B cells 17, 18 . The origin of these atypical memory cells is unclear but, given their presence in such immune deficient patients, they may arise independently of a conventional GC pathway [18] [19] [20] . Interestingly such IgM + IgD + CD27
+ memory B cells are also present in the blood and spleen of healthy individuals 21, 22 but, like the naïve cell fraction, they are reportedly not a reservoir for EBV persistence 3 . Here we focus on one such immune deficiency characterised by memory B cell impairment, X-linked lymphoproliferative disease (XLP). This is associated with mutations in SH2D1A that encodes SAP [23] [24] [25] , a protein involved in the regulation of B cell-T cell interactions mediated by members of the SLAM family of cell surface receptors [26] [27] [28] . SAP is selectively expressed in T and NK cells, rather than B cells 15 , and SAP deficiency abrogates the delivery of CD4 + T cell help to B cells necessary for the generation of fully functional GCs and hence for the production of class-switched memory B cells 14, 29, 30 . One of the clinical symptoms shown by XLP, therefore, is hypogammaglobulinaemia and an inability to mount IgG or IgA antibody responses; moreover, from the histologic analysis of splenic tissues, this is associated with an inability to form recognisable GC structures 15 .
Virus carriage in boys with XLP has not previously been analysed in detail, not least because B cell subsets in the blood or just the "non-switched", potentially GC-independent, memory pool?
MATERIALS AND METHODS

Donors
Peripheral blood samples were collected with informed consent from normal healthy donors, from XLP patients and from an EBV-AHS patient. All studies were approved by the Central (in which 10% cells were in lytic cycle) into an excess of EBV-negative BJAB cells, all three assays were capable of detecting the presence of a single lytically-infected cell (data not shown).
Heteroduplex tracking assays
EBV isolates were characterised on the basis of sequence polymorphisms within the EBNA2 and LMP1 latent genes using established heteroduplex tracking assays (HTA) 43, 44 . Aliquots of DNA from ex vivo PBMC samples were subjected to nested PCR amplification using primers specific for EBNA2 and LMP1. The subsequent product/probe binding reactions and heteroduplex analysis were performed as previously described 44 .
RESULTS
High EBV loads in XLP patients involve the B cell compartment
A total of 8 XLP patients were studied during the course of this work. Table 1 gives their age and clinical phenotype at time of sampling, and indicates whether or not they had an earlier history of a fulminant IM episode. In an initial series of experiments, PBMCs from six of these patients (XLP1-6) were assayed for EBV DNA load by quantitative PCR alongside control samples from 12
healthy EBV carriers and, as a comparator, PBMCs from a rare patient who presented with acute EBV-AHS. As shown in Figure 1A , all six XLP patients' samples were found to be EBV-positive with levels of infection spread across an unusually wide range, individual results being shown in Table 1 . In particular three of the six XLP patients had loads either at the top of or (for XLP5)
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We then positively selected B cells from the PBMCs of four of these patients (XLP1-4) and of the EBV-AHS patient using CD19 antibody-coated Dynabeads, a procedure that routinely yields B cell-enriched preparations with >98% purity and leaves depleted preparations with <5% B cell contaminants, as judged by staining for a second B cell marker, CD20 (data not shown). These paired preparations were examined for EBV load, the data being shown in Figure 1B While healthy individuals are known to carry EBV in the circulating B cell pool as an exclusively latent infection 3 , it remained possible that the situation in XLP patients may be different and that on-going virus replication might be contributing to the often-elevated viral loads seen in the above patients. To examine this, we developed sensitive quantitative RT-PCR assays for three EBV lytic cycle transcripts, the immediate early gene BZLF1, and two late genes BVRF2 (protease) and BLLF1 (gp350). These assays were each capable of detecting the presence of a single lyticallyinfected B95.8 cell in in vitro-reconstructed cell mixtures. However, these same assays never detected the presence of such transcripts in RNA isolated from the purified B cells of XLP patients, including B cells from XLP5, the patient with the highest viral load (data not shown). We infer from this that virus load assays are truly reflecting the latent genome load in the circulating B cells of these patients.
EBV is concentrated in the non-switched memory B cells of XLP patients
Four of the available XLP patients from whom larger blood samples could be obtained (XLP5-8)
were chosen for more detailed analysis and compared to 6 healthy donor controls. Their PBMCs were co-stained with anti-CD20 and anti-CD27 mAbs to identify naïve (i. Figure 2A and overall results are summarised in Figure 2B . In agreement with a previous study 14 , total B cell numbers were not significantly different between patients and healthy controls. However, the distribution of B-cell subsets was quite different. Figure 2A ).
The above PBMC samples from XLP patients that had been triple-stained for CD20, CD10 and CD27 were then sorted by FACS to isolate the transitional (CD20 + CD10 + CD27 -), naïve (CD20 + CD10 -CD27 -) and memory (CD20 + CD10 -CD27 + ) cell populations; these gave typical sort purities of 95-98% for each of the subsets, as published [14] [15] [16] . Figure 3 illustrates the data obtained when these different subsets were analysed for EBV DNA load and shows that, in each case, the virus was highly enriched in the memory subset. In particular, the virus load in memory cells was always >100-fold higher than in transitional cells and, depending on the patient, was between 10-and 300-fold higher than in naïve cells. As shown in earlier work 15 not isolate a class-switched cell population from these samples, whereas we could readily obtain naïve and non-switched memory populations. With this sorting protocol, re-analysis showed that the naïve cell sorts were of high purity, while the non-switched memory cells gave purities of 91% for XLP5 and 77% for XLP6 (the lower XLP6 value reflecting the difficulty of sorting a population that is at low frequency in the initial sample); in both cases, however, the vast majority of the contaminants within the non-switched population are IgM + IgD + CD27 -naïve cells. Figure 4B shows the corresponding EBV DNA load data from these sorted populations compared to the load seen in unfractionated B cells from the same patient. In both cases the virus was predominantly found in the non-switched memory population.
Stability of the virus load and of the resident EBV strain in XLP patients
For these two patients (XLP5, XLP6) in whom the virus had been definitively localised to the nonswitched memory B cell pool, successive bleeds had been taken and PBMCs stored over periods of
years respectively. These samples were screened in parallel by quantitative PCR and the EBV load data are shown in Figure 5A . While the two patients had quite different EBV load values, each retained their own characteristic load at a roughly stable level over the period of study.
Such stability is consistent with the view that these patients are maintaining their EBV-positive status through persistence of a long-term infection rather than through a series of transient infections, each of which is cleared and then replaced by another exogenously acquired EBV strain.
A more definitive resolution of the point became possible with the development of heteroduplex tracking assays to identify the resident EBV strain or strains within an individual. These assays involve amplifying viral DNA from ex vivo samples across non-linked polymorphisms in the EBNA2 and LMP1 regions in the virus genome and in each case identifying the allelic products through the mobility of heteroduplexes that form with a standard labelled probe 44 . We applied these assays to the successive blood samples from the above two patients. Figure 5B shows the data obtained from XLP5 DNA samples taken over a 3 year period, the amplification products being run alongside those from reference EBV strains representing five different alleles of the EBNA2 locus commonly seen among type 1 EBV strains and five of the known alleles of the LMP1 locus. At each time point, the virus strain present in patient XLP5 had a 1.3B allele at the EBNA2 locus and a Med -allele at the LMP1 locus. The correct identification of these alleles was later confirmed by DNA sequence analysis (data not shown). The second prospectively studied patient gave similar results, with a single EBNA2 and a single LMP1 allelic sequence maintained throughout (data not shown).
DISCUSSION
The seminal observation that EBV persistence in healthy virus carriers is associated with selective We first showed by Q-PCR for the viral genome that all patients did carry EBV in the circulating PBMC population. In some cases, the virus load was well within the normal range, while in other cases it was unusually high; although patient numbers were small, it is interesting to note that individuals with the higher loads were not necessarily those who had a prior history of fulminant IM ( showed that it did indeed harbour the virus.
There are some parallels between the above findings and those described in an earlier study of EBV infection in patients with hyper-IgM syndrome arising from CD40L deficiency 54 . These patients also are unable to form conventional GCs and lack isotype-switched memory B cells 20, 55, 56 . In that study, virus DNA could be detected on at least one occasion in the blood and/or throat washings of 6 of 9 patients analysed. However the levels were low, often close to the threshold of detection, and + population in patients lacking classical memory B cells and can do so at high levels. We also addressed the question of virus persistence using blood samples taken prospectively over 3-4 years from two different XLP patients, one with an unusually high load in IgM + IgD + CD27 + B cells, the other with a lower load. Those particular loads were maintained at roughly stable levels over the whole period of study. Moreover, using two independent and highly polymorphic markers of virus strain identity situated within the EBNA2 and LMP1 genes respectively, we found both patients retained one characteristic strain throughout. Such constancy of virus load and of virus identity is indicative of a persistent rather than a recurring infection.
The present findings therefore demonstrate that, in patients who lack conventional isotypeswitched memory B cells and who from histologic analysis of splenic tissues 15 
presence in XLP and CD40L-deficient patients has led some investigators to propose that they are not antigen-instructed memory cells in the true sense; rather, it is suggested, they are B cells that have undergone somatic hypermutation during generation of the pre-immune repertoire and later mount antibody responses to T cell-independent antigens only 19, 20 . As such, these cells would be GC-independent both in their generation and function. From this viewpoint, therefore, the detection of EBV within this population in XLP patients might be used to argue against any involvement of the GC reaction in virus colonisation of the B cell system. However We would stress that the present findings were made in individuals with a complex immunodeficiency, XLP, where an impairment of specific cytokine production by TH2-like CD4 of EBV sequences present in the same PBMC samples from patient XLP5 using EBNA2 and LMP1 HTAs. In the upper panel, PBMC DNA was PCR-amplified using type 1 specific EBNA2 primers and the resulting PCR products analysed by HTA using a 1.1 EBNA2 allele-specific probe. Also shown are the results from a panel of reference control isolates known to carry a 1.1, 
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